First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study

Overview of attention for article published in Rheumatology and Therapy, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 489)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 5 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 43 Mendeley

Summary News Policy documents X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 public wall post.

Lupus Brothers & Sisters, 09 Jan 2017

Most lupus patients who added Benlysta (belimumab) to their treatment regimen improved, according to research in Germany. …